metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-10 SEROPREVALENCE OF CHRONIC HEPATITIS C INFECTION AND VIROLOGICAL CURE WITH A...
Journal Information
Vol. 29. Issue S3.
Abstracts of the 2023 Annual Meeting of the ALEH
(December 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S3.
Abstracts of the 2023 Annual Meeting of the ALEH
(December 2024)
Full text access
P-10 SEROPREVALENCE OF CHRONIC HEPATITIS C INFECTION AND VIROLOGICAL CURE WITH A DAILY ADMINISTRATION SYSTEM OF NS3/4A PROTEASE INHIBITOR AND NS5A INHIBITOR IN IMPRISONED PATIENTS.
Visits
7
VÍCTOR MANUEL FONG FLORES1, Omar Perez Carreon2, Andres Flores Gomez1, Andres Murillo Gallo3, Alfredo Ojeda Garmendia2, Mariana Marquez2
1 CAPASITS LOS CABOS, Los Cabos, México
2 CAPASITS La Paz, La Paz, México
3 Hospital Juan Maria de Salvatierra, La Paz, México
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 29. Issue S3

Abstracts of the 2023 Annual Meeting of the ALEH

More info
Conflict of interest

No

Introduction and Objectives

Hepatitis C infection has a high prevalence in social rehabilitation centers and prissions; however, patient migration, lack of adherence monitoring and risk practices are determinants for abandoning treatment. Objectives: Determine the seroprevalence in patients deprived of their liberty in social rehabilitation centers for chronic hepatitis C infection, as well as evaluate the effectiveness of daily provision of antivirals in patients who are deprived of their liberty.

Patients / Materials and Methods

Information was collected through the national hepatitis C elimination program database in patients screened for HIV infection, syphilis and hepatitis C during the period 2021-2024 in Baja California Sur, Mexico. Mass screening tests were performed with serological antigen and PCR for hepatitis C. Those patients with a positive viral load were treated with direct-acting antivirals for 2 months and a viral load was performed to verify sustained viral response. During this period, medical teams supplied the drug in a controlled manner provided by the health services in prisons. To keep the rehabilitation centers free of hepatitis C, serologies were implemented under informed consent for newly admitted people that were admitted.

Results and Discussion

3452 rapid tests were performed, of which 77 tests (2.23%) were reactive with positive viral load in 76 cases (98.07%), all patients were male (100%), with an average age of 42.1 years. Of the patients studied, the main risk factor was intravenous drug use (98%). Viral loads were measured 3 months after treatment where 98.68% had virological cure, 1.3% migrated from a social rehabilitation center and 0% presented virological failure.

Conclusions

The intervention of health services continuously and jointly with the penal system is a determining factor in achieving virological cure and rehabilitation centers free of hepatitis C.

Full text is only aviable in PDF
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos